| MRKR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MRKR market cap history going back to 8/2/2018:
Also see: MRKR Shares Outstanding History and MRKR YTD Return |
MRKR Market Cap History — Marker Therapeutics Capitalization Over Time
As of 8/7/2026 Marker Therapeutics has a market cap of 18.67 million. Investors often follow the MRKR market cap history to compare the size of the company over time.
This page shows MRKR market capitalization trends over time, with 31 market cap datapoints presented, dating back to 8/2/2018.
| MRKR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MRKR Historical Market Cap: -19.61% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MRKR Stock Price Chart |
| About Marker Therapeutics Inc |
| Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. Co. specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It has developed its lead product candidates from its multiTAA-specific T cell technology, which is based on the manufacture of non-engineered, tumor-specific T cells that recognize multiple tumors associated antigens (TAAs), which are tumor targets, and kill tumor cells expressing those targets. We show 31 historical shares outstanding datapoints in our MRKR shares outstanding history coverage, used to compute MRKR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MRKR market cap history over the course of time is important for investors interested in comparing MRKR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MRKR versus a peer is one thing; comparing MRKR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MRKR can fluctuate over the course of history. With this page we aim to empower investors researching MRKR by allowing them to research the MRKR market cap history. |
| MRKR Current Stock Quote |
Quotes delayed 20 minutes  Free MRKR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| MRKR Share Performance |
| Market Cap Peers |
| Marker Therapeutics (MRKR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MRNA Market Cap History MRNS Market Cap History MRSN Market Cap History MRTX Market Cap History MRVI Market Cap History MSON Market Cap History MTCR Market Cap History MTEM Market Cap History MTVA Market Cap History MXCT Market Cap History More Healthcare companies » |
MRKR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
